Study of APN201 (Liposomal Recombinant Human Cu/Zn-Superoxide Dismutase) for the Prevention of Radiation-induced Dermatitis in Women With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Radiation Induced Dermatitis
Interventions: DRUG: APN201|DRUG: Placebo
Sponsor: Apeiron Biologics